Fred Saad - Publications, H-index & Citations

Fred Saad

University of Montreal Hospital Center

127H指数

1.9K论文数

10.8W被引数

收录论文 538

发表时间

Alkaline Phosphatase and Prostate-specific Antigen Response in Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide Alone or in Combination with Radium-223: Ad Hoc Analysis of the PEACE-3 Consortium Trial 碱性磷酸酶和前列腺特异性抗原在转移性去势抵抗性前列腺癌中，经恩扎卢胺单药或联合镭-223治疗后的反应：PEACE-3联盟试验的临时分析

European Urology Oncology

IF9.3

2026-08-28

OAAI

Andrey Soares; Silke Gillessen; Ananya Choudhury; Fred Saad; Enrique Gallardo; Yohann Loriot; Raymond S. McDermott; Alejo Rodriguez-Vida; Pedro Isaacsson Velho; Franco Nolè; Felipe Melo Cruz; Thierry André Roumeguère; Gedske Daugaard; Rosely Yamamura; Coralie Poncet; Corneel Coens; Béatrice Fournier; Bertrand F. Tombal

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial [177Lu]Lu-PSMA-617在PSMA阳性转移性雄激素通路调节剂初治/敏感的前列腺癌患者中的应用（PSMAddition）：一项3期随机对照试验

The Lancet

IF88.5

2026-08-06

PREAI

Scott T Tagawa; Oliver Sartor; Josep M Piulats; Fred Saad; Karim Fizazi; Alison Reid; Himisha Beltran; Gero Kramer; Hakim Mahammedi; Matthias Eiber; Shilpa Gupta; Daniel Castellano; Ralph Hauke; Hyun Kim; Cheol Kwak; See Tong Pang; Philippe Barthélémy; Dong Dai; Jae Lyun Lee; Luke Nordquist

Luteinizing hormone-releasing hormone in prostate cancer treatment: from hypothalamic discovery to clinical translation 促黄体生成素释放激素在前列腺癌治疗中的应用：从下丘脑发现到临床转化

JNCI Cancer Spectrum

IF4.1

2026-07-13

OAAI

Samuel Benisti, MD; Fred Saad, MD; Guila Delouya, MD, MSc; Daniel Taussky, MD

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial 纳武利尤单抗联合伊匹木单抗治疗化疗难治性转移性去势抵抗性前列腺癌：来自CheckMate 650试验2期随机部分的结果

Nature Communications

IF15.7

2026-05-08

OAAI

Padmanee Sharma; Michael Krainer; Fred Saad; Daniel Castellano; Jens Bedke; Mariusz Kwiatkowski; Akash Patnaik; Giuseppe Procopio; Paweł Wiechno; Samith Kochuparambil; Christian Thomas; José Ángel Arranz Arija; Steven L. McCune; Steinbjørn Hansen; Gedske Daugaard; Juan Ignacio Delgado Mingorance; Craig Kukard; Sumit K. Subudhi; Sreyashi Basu; Sonali Jindal; Bilal A. Siddiqui; Ana Lako; Saurabh Gupta; Viktor Fedorov; Neha P. Amin; Arancha Campos; Yumeng Wang; Justin M. David; Russell K. Pachynski

Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial 达罗鲁胺治疗转移性激素敏感型前列腺癌的疼痛和健康相关生活质量结局（ARANOTE）：一项多中心、随机、安慰剂对照III期试验的次要和探索性分析

The Lancet Oncology

IF0

2026-04-09

PREAI

Alicia K Morgans; Kunhi Parambath Haresh; Mindaugas Jievaltas; David Olmos; Neal D Shore; Egils Vjaters; Nianzeng Xing; Ateesha F Mohamed; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Fred Saad

Efficacy and safety of darolutamide in combination with androgen deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial 达罗他胺联合雄激素剥夺疗法和多西他赛在欧洲患者中的疗效和安全性：来自III期ARASENS试验的数据

European Journal of Cancer

IF7.1

2026-04-05

PREAI

Bertrand Tombal; Maha Hussain; Fred Saad; Karim Fizazi; Neal Shore; Evgeny Kopyltsov; Martin Bögemann; Maria J Mendez-Vidal; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Matthew R. Smith

Adverse in-hospital outcomes after radical or partial nephrectomy in cardiac transplant patients 心脏移植患者接受根治性或部分肾切除术后的院内不良结局

World Journal of Urology

IF2.9

2025-12-29

PREAI

Federico Polverino; Calogero Catanzaro; Michele Nicolazzini; Michele Petix; Leonardo Quarta; Maximilian Filzmayer; Nick Lee; Jordan A. Goyal; Simone Morra; Claudia Collà Ruvolo; Massimiliano Creta; Gianluigi Califano; Alberto Briganti; Felix K. H. Chun; Carlotta Palumbo; Riccardo Schiavina; Gennaro Musi; Shahrokh F. Shariat; Fred Saad; Nicola Longo; Pierre I. Karakiewicz

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer 早期对转移性激素敏感型前列腺癌的 prostate-specific antigen (PSA) 阳性反应预测

Nature Communications

IF15.7

2025-12-17

OAAI

Soumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt

The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria 根据纳入标准的部分膀胱切除术中盆腔淋巴结清扫对癌症特异性死亡率的影响

Annals of Surgical Oncology

IF3.5

2025-12-03

PREAI

Mattia Longoni; Quynh Chi Le; Fabian Falkenbach; Andrea Marmiroli; Michele Nicolazzini; Calogero Catanzaro; Federico Polverino; Jordan A. Goyal; Markus Graefen; Matteo Ferro; Felix K. H. Chun; Carlotta Palumbo; Riccardo Schiavina; Nicola Longo; Fred Saad; Shahrokh F. Shariat; Leonardo Quarta; Marco Moschini; Giorgio Gandaglia; Francesco Montorsi; Alberto Briganti; Pierre I. Karakiewicz

Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study 在PROpel III期研究中，接受奥拉帕利联合阿比特龙治疗或安慰剂联合阿比特龙治疗转移性去势抵抗性前列腺癌患者的患者报告结局。

European Urology Oncology

IF9.3

2025-11-17

OAAI

Andrew J. Armstrong; Fred Saad; Mototsugu Oya; Karina Vianna; Mustafa Özgüroğlu; Craig Gedye; Gary L. Buchschacher; Ji Youl Lee; Urban Emmenegger; Jiří Navrátil; Juan Antonio Virizuela; Anibal Salazar; Denis Maillet; Hiroji Uemura; Christian Hosius; David McGuinness; Arnold Degboe; Noel Clarke

Corrigendum to Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study [European Journal of Cancer Volume 213, December 2024, 115078]勘误：Talazoparib 联合 enzalutamide 治疗 metastatic castration-resistant prostate cancer 的安全性分析，来自随机、安慰剂对照、III 期 TALAPRO-2 研究的结果 [European Journal of Cancer Volume 213, December 2024, 115078]

European Journal of Cancer

IF7.1

2025-11-13

PREAI

Arun A. Azad; Karim Fizazi; Nobuaki Matsubara; Fred Saad; Ugo De Giorgi; Jae Young Joung; Peter C.C. Fong; Robert J. Jones; Stefanie Zschäbitz; Jan Oldenburg; Neal D. Shore; Curtis Dunshee; Joan Carles; Andre P. Fay; Xun Lin; Liza DeAnnuntis; Nicola Di Santo; Michael A. Zielinski; Neeraj Agarwal

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes 机器人辅助与开放性部分细胞减灭术肾切除术在转移性肾细胞癌中的院内不良结局比较

World Journal of Urology

IF2.9

2025-11-11

OAAI

Quynh Chi Le; Mattia Longoni; Andrea Marmiroli; Fabian Falkenbach; Calogero Catanzaro; Michele Nicolazzini; Federico Polverino; Jordan A. Goyal; Fred Saad; Riccardo Schiavina; Luca Fabio Carmignani; Alberto Briganti; Nicola Longo; Markus Graefen; Carlotta Palumbo; Miriam Traumann; Felix K.-H. Chun; Pierre I. Karakiewicz

Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer 前列腺特异性抗原和客观缓解分析在PROpel研究中：奥拉帕利联合阿比特龙对比安慰剂联合阿比特龙作为转移性去势抵抗性前列腺癌的一线疗法

European Urology Oncology

IF9.3

2025-11-04

OAAI

Fred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke

European Urology Oncology

IF9.3

2025-11-04

OAAI

Joan Carles; Bertrand Tombal; Maha Hussain; Fred Saad; Karim Fizazi; Álvaro Montesa Pino; Maria José Méndez-Vidal; Alejo Rodriguez-Vida; Daniel Castellano; Pablo Borrega; Patrick Adorjan; Cristina Moretones; Manjari Dissanayake; Matthew R. Smith

A plain language summary of the EORTC 1333/PEACE-3 study of enzalutamide alone vs enzalutamide plus radium-223 in patients with metastatic castrationresistant prostate cancer (mCRPC) and bone metastases EORTC 1333/PEACE-3研究的通俗摘要：恩扎卢胺单药与恩扎卢胺联合镭-223治疗伴有骨转移的转移性去势抵抗性前列腺癌（mCRPC）患者的比较研究

FUTURE ONCOLOGY

IF2.6

2025-11-01

PREAI

Tombal, Bertrand; Saad, Fred; Gallardo, Enrique; Soares, Andrey; Loriot, Yohann; McDermott, Ray; Briers, Erik; Lagstrom, Mikael; Coens, Corneel; Poncet, Coralie; Fournier, Beatrice; Gillessen, Silke

Rates of Secondary Bladder and Rectal Cancers After External Beam Radiation for Prostate Cancer According to Age and D'amico Risk Groups in A Contemporary Cohort 根据年龄和D'amico风险组，当代队列中前列腺癌外照射放疗后继发性膀胱和直肠癌的发生率

Clinical Genitourinary Cancer

IF2.7

2025-11-01

PREAI

De Angelis, Mario; Siech, Carolin; Jannello, Letizia Maria Ippolita; Di Bello, Francesco; Penaranda, Natali Rodriguez; Scilipoti, Pietro; Longoni, Mattia; Goyal, Jordan A.; Tian, Zhe; Longo, Nicola; De Cobelli, Ottavio; Musi, Gennaro; Chun, Felix K. H.; Puliatti, Stefano; Saad, Fred; Shariat, Shahrokh F.; Gandaglia, Giorgio; Moschini, Marco; Montorsi, Francesco; Briganti, Alberto; Karakiewicz, Pierre I.

Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinoma

SURGICAL ONCOLOGY-OXFORD

IF2.4

2025-11-01

PREAI

Incesu, Reha-Baris; Scheipner, Lukas; Morra, Simone; Baudo, Andrea; Siech, Carolin; Jannello, Letizia Maria Ippolita; de Angelis, Mario; Assad, Anis; Tian, Zhe; Saad, Fred; Shariat, Shahrokh F.; Briganti, Alberto; de Cobelli, Ottavio; Chun, Felix K. H.; Carmignani, Luca; Longo, Nicola; Ahyai, Sascha; Tilki, Derya; Graefen, Markus; Karakiewicz, Pierre I.

Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy 截瘫患者接受根治性前列腺切除术的院内不良结局

BJU International

IF4.4

2025-10-10

OAAI

Andrea Marmiroli; Francesco Di Bello; Natali Rodriguez Peñaranda; Mattia Longoni; Quynh Chi Le; Fabian Falkenbach; Michele Nicolazzini; Calogero Catanzaro; Zhe Tian; Jordan A. Goyal; Stefano Luzzago; Francesco Alessandro Mistretta; Mattia Piccinelli; Fred Saad; Shahrokh F. Shariat; Alberto Briganti; Felix K. H. Chun; Salvatore Micali; Nicola Longo; Markus Graefen; Carlotta Palumbo; Riccardo Schiavina; Gennaro Musi; Pierre I. Karakiewicz

Effect of neoadjuvant chemotherapy on years of life lost in radical cystectomy-treated T2N0M0 bladder cancer patients 新辅助化疗对接受根治性膀胱切除术治疗的T2N0M0膀胱癌患者寿命损失年的影响

World Journal of Urology

IF2.9

2025-10-04

PREAI

Mattia Longoni; Fabian Falkenbach; Andrea Marmiroli; Quynh Chi Le; Michele Nicolazzini; Calogero Catanzaro; Federico Polverino; Jordan A. Goyal; Markus Graefen; Matteo Ferro; Felix K. H. Chun; Alessandro Volpe; Riccardo Schiavina; Nicola Longo; Fred Saad; Shahrokh F. Shariat; Leonardo Quarta; Marco Moschini; Giorgio Gandaglia; Francesco Montorsi; Alberto Briganti; Pierre I. Karakiewicz

Perioperative Radiotherapy and Survival After Surgical Treatment of Nonmetastatic Retroperitoneal Sarcoma 围手术期放疗及非转移性腹膜后肉瘤外科治疗后的生存情况

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-10-01

PREAI

Baudo, Andrea; De Angelis, Mario; Siech, Carolin; Jannello, Letizia Maria Ippolita; Di Bello, Francesco; Goyal, Jordan A.; Tian, Zhe; Acquati, Pietro; Conti, Andrea; Vizziello, Damiano; Briganti, Alberto; Chun, Felix K. H.; De Cobelli, Ottavio; Longo, Nicola; Califano, Gianluigi; Saad, Fred; Shariat, Shahrokh F.; Carmignani, Luca; Karakiewicz, Pierre I.

研究方向